United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 29, 2026 · Filed Jul 30, 2026

On Jul 29, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$522.37 for US$4.96M under a trading plan, leaving 324,443 shares. Filed Jul 30, 2026 (Form 4).

Sold
9,500 shares
Price
US$522.37 average (US$518.25 to US$525.46)
Value
US$4.96M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 29, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 29, 2026Common StockSale798US$518.25333,145Indirect
Jul 29, 2026Common StockSale1,112US$519.29332,033Indirect
Jul 29, 2026Common StockSale900US$520.40331,133Indirect
Jul 29, 2026Common StockSale1,270US$521.32329,863Indirect
Jul 29, 2026Common StockSale880US$522.51328,983Indirect
Jul 29, 2026Common StockSale1,318US$523.63327,665Indirect
Jul 29, 2026Common StockSale1,982US$524.47325,683Indirect
Jul 29, 2026Common StockSale1,240US$525.46324,443Indirect

Source

View original at SEC

Related